PharmaResources (Shanghai) Co., Ltd. (SHE:301230)

China flag China · Delayed Price · Currency is CNY
41.95
+0.35 (0.84%)
At close: Apr 29, 2026
57.06%
Market Cap 5.77B
Revenue (ttm) 691.21M
Net Income (ttm) 46.10M
Shares Out 137.54M
EPS (ttm) 0.32
PE Ratio 131.59
Forward PE n/a
Dividend 0.50 (1.20%)
Ex-Dividend Date Jan 13, 2026
Volume 7,896,403
Average Volume 10,863,679
Open 40.99
Previous Close 41.60
Day's Range 39.60 - 42.79
52-Week Range 27.70 - 67.97
Beta 1.28
RSI 52.58
Earnings Date Apr 29, 2026

About SHE:301230

PharmaResources (Shanghai) Co., Ltd. engages in new drug research, development, and commercial production in China. It offers small molecule drug CRO, CDMO, and CMO. The company also involved in drug discovery, research, and development of pharmaceutical processes; and customized and commercial production of APIs, and key intermediates. It serves global pharmaceutical and biotechnology companies. PharmaResources (Shanghai) Co., Ltd. was founded in 2007 and is based in Shanghai, China [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2007
Employees 1,085
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301230
Full Company Profile

Financial Performance

In 2025, SHE:301230's revenue was 688.35 million, an increase of 26.43% compared to the previous year's 544.47 million. Earnings were 34.29 million, an increase of 100.75%.

Financial Statements

News

There is no news available yet.